vitiligo
Information
- Disease name
- vitiligo
- Disease ID
- DOID:12306
- Description
- "An autoimmune disease that causes depigmentation of patches of skin resulting from loss of function or death of melanoctyes." [url:http\://en.wikipedia.org/wiki/Vitiligo] {comment="ls:IEDB"}
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05342519 | Active, not recruiting | Phase 2 | Daily Topical Rapamycin for Vitiligo | July 28, 2022 | August 1, 2024 |
| NCT04338581 | Active, not recruiting | Phase 2 | Evaluation of AMG 714 for Vitiligo | December 11, 2020 | May 2025 |
| NCT04971200 | Active, not recruiting | Early Phase 1 | Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo | September 16, 2021 | April 2024 |
| NCT05971381 | Active, not recruiting | N/A | Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells | August 14, 2023 | January 2025 |
| NCT06097494 | Active, not recruiting | Investigating Healthcare Disparities in Vitiligo | July 20, 2023 | November 15, 2024 | |
| NCT00368407 | Completed | Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck | April 2005 | July 2006 | |
| NCT00398723 | Completed | N/A | Narrowband UVB Treatment in Patients With Vitiligo | November 2006 | November 2007 |
| NCT06035614 | Completed | N/A | Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children | October 1, 2022 | July 1, 2023 |
| NCT00615355 | Completed | N/A | Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment | February 2008 | December 2015 |
| NCT00622180 | Completed | N/A | The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands | January 2008 | March 2009 |
| NCT00631865 | Completed | Phase 3 | Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin | February 2009 | May 2015 |
| NCT00696358 | Completed | Phase 3 | Excimer Lamp Versus Excimer Laser in Vitiligo Treatment | ||
| NCT05968235 | Completed | Correlation of Glucose and Lipid Metabolism Levels With Vitiligo | February 1, 2020 | March 25, 2023 | |
| NCT00807690 | Completed | Phase 3 | Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo | November 2005 | January 2008 |
| NCT00830713 | Completed | Phase 3 | Vitiligo Skin Transplantation | January 2009 | October 2011 |
| NCT05676333 | Completed | Phase 4 | Secukinumab in Active Non-segmental Vitiligo | October 12, 2016 | February 22, 2019 |
| NCT01051687 | Completed | Phase 4 | Botulinum Toxin Treatment for Localized Vitiligo | April 2009 | January 2010 |
| NCT01082393 | Completed | Phase 4 | Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) | February 16, 2010 | December 1, 2015 |
| NCT01087216 | Completed | Phase 2/Phase 3 | Interest of the Dermabrasion by Laser Erbium in the Treatment of the Vitiligo | March 2010 | March 2011 |
| NCT05577637 | Completed | Phase 1 | Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo | May 1, 2021 | November 30, 2021 |
| NCT05513924 | Completed | Phase 2/Phase 3 | Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo. | March 15, 2022 | December 1, 2022 |
| NCT05506995 | Completed | Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo | August 1, 2021 | August 3, 2022 | |
| NCT05364567 | Completed | N/A | Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency | May 1, 2018 | May 1, 2022 |
| NCT01382589 | Completed | Phase 2 | Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo | September 2011 | December 2012 |
| NCT01430195 | Completed | Phase 1 | Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV) | June 2011 | November 2012 |
| NCT05298033 | Completed | Phase 2 | Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo | September 7, 2022 | April 30, 2024 |
| NCT01478945 | Completed | N/A | HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home | February 2012 | April 2013 |
| NCT01511965 | Completed | Phase 1/Phase 2 | Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo | May 2011 | November 2012 |
| NCT01517893 | Completed | Phase 2 | Clinical Trial of Simvastatin to Treat Generalized Vitiligo | January 2012 | December 2014 |
| NCT01629979 | Completed | Phase 2/Phase 3 | Epidermal Cell Transplantation in Vitiligo Skin | May 2011 | November 2012 |
| NCT01732965 | Completed | Phase 4 | NB-UVB and PUVA Vitiligo Study | March 2013 | May 2014 |
| NCT05247489 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo | May 5, 2022 | December 19, 2023 |
| NCT05098600 | Completed | The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic | October 15, 2021 | December 20, 2022 | |
| NCT05053022 | Completed | N/A | A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo | July 29, 2021 | January 24, 2023 |
| NCT05037981 | Completed | Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo | October 10, 2015 | August 20, 2021 | |
| NCT03608917 | Completed | N/A | Efficacy and Safety of Total Glucosides of Paeony Combined With NB-UVB on Treating Vitiligo | April 17, 2018 | July 31, 2019 |
| NCT00167752 | Completed | Psychiatric Problems in Chronic Skin Diseases | December 2002 | ||
| NCT00134368 | Completed | Phase 2 | Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo | November 2003 | December 2007 |
| NCT06209138 | Completed | N/A | 5-fluorouracil for Treatment of Stable Vitiligo | January 23, 2024 | April 15, 2024 |
| NCT00367224 | Completed | N/A | Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo | January 2006 | May 2008 |
| NCT03741738 | Completed | The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity | August 30, 2018 | June 9, 2020 | |
| NCT03622320 | Completed | Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo | July 1, 2018 | June 30, 2019 | |
| NCT04969419 | Completed | Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo | June 18, 2021 | April 4, 2023 | |
| NCT01992185 | Completed | N/A | Photocil (Topical) for the Treatment of Vitiligo | August 2013 | December 2014 |
| NCT04953338 | Completed | Mental Health Associations With Vitiligo | June 18, 2021 | October 21, 2022 | |
| NCT02156427 | Completed | Phase 3 | Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism | April 29, 2014 | April 10, 2018 |
| NCT04896385 | Completed | Phase 2 | A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA) | June 23, 2021 | July 10, 2023 |
| NCT04872257 | Completed | N/A | Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo | September 14, 2021 | November 1, 2022 |
| NCT04822584 | Completed | Phase 2 | Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo | July 16, 2021 | April 26, 2023 |
| NCT02432534 | Completed | Phase 2 | Atorvastatin in Active Vitiligo | May 2015 | December 2017 |
| NCT02466997 | Completed | Phase 3 | Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC | February 23, 2016 | September 30, 2018 |
| NCT04775979 | Completed | Phase 4 | Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo | January 17, 2021 | August 30, 2021 |
| NCT02510651 | Completed | Phase 1 | Effect of Procedural Variables on Outcome of Surgical Treatment of Vitiligo | January 2010 | June 2014 |
| NCT04738149 | Completed | Early Phase 1 | Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment | November 2, 2021 | May 15, 2022 |
| NCT02797574 | Completed | N/A | Stress Response Pathways in Vitiligo | October 2015 | September 22, 2021 |
| NCT02809976 | Completed | Phase 2 | Topical Ruxolitinib for the Treatment of Vitiligo | January 2016 | February 2017 |
| NCT04547998 | Completed | N/A | Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions | September 10, 2020 | January 31, 2023 |
| NCT04530344 | Completed | Phase 3 | Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo | September 24, 2020 | November 14, 2022 |
| NCT04525157 | Completed | Phase 2 | Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV) | June 6, 2014 | June 6, 2016 |
| NCT03036995 | Completed | Phase 2 | Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO | March 20, 2017 | November 25, 2019 |
| NCT03047733 | Completed | N/A | Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo | July 21, 2015 | December 31, 2016 |
| NCT03099304 | Completed | Phase 2 | A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo | June 7, 2017 | September 8, 2021 |
| NCT03123016 | Completed | Phase 2 | Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo | April 14, 2017 | August 5, 2019 |
| NCT03133871 | Completed | Evaluation of Scanoskin for the Assessment of Vitiligo | March 1, 2017 | November 20, 2018 | |
| NCT04239521 | Completed | The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata | October 1, 2020 | November 28, 2022 | |
| NCT04103060 | Completed | Phase 2 | Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo | September 27, 2019 | November 3, 2020 |
| NCT03973073 | Completed | Phase 1 | Effects of Combination Therapy With Camouflage in the Repigmentation of Vitiligo | August 1, 2019 | November 21, 2019 |
| NCT03249064 | Completed | Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo | October 27, 2015 | September 13, 2016 | |
| NCT03270241 | Completed | N/A | Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy | October 1, 2017 | March 14, 2023 |
| NCT03323125 | Completed | Photoprotection Habits in Patients With Vitiligo | October 16, 2017 | April 16, 2018 | |
| NCT03941808 | Completed | N/A | Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo. | June 17, 2019 | December 1, 2020 |
| NCT03941184 | Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | January 1, 1995 | November 10, 2020 | |
| NCT03933774 | Completed | N/A | PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation | April 29, 2019 | November 29, 2019 |
| NCT03367273 | Completed | N/A | Thymic Stromal Lymphopoietin (TSLP) in Vitiligo | January 2017 | July 2017 |
| NCT03864315 | Completed | N/A | To Study the Efficacy of Therapeutic Pulsed Ultrasound in the Treatment of Vitiligo: a Randomized, Intra-individual, Left-right Comparison Study | July 1, 2014 | December 9, 2015 |
| NCT03859518 | Completed | Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo | July 2016 | December 2019 | |
| NCT03411135 | Completed | Vitiligo Extent Score (VES) Score in Comparison to Vitiligo Area and Severity Index (VASI) Score | April 2016 | September 2016 | |
| NCT03468855 | Completed | Phase 2 | A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo | March 19, 2018 | October 16, 2019 |
| NCT03762551 | Completed | N/A | Janus Kinase 1 in Vitiligo & Psoriasis | December 2015 | November 2016 |
| NCT05084417 | Enrolling by invitation | A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions | June 9, 2023 | January 15, 2026 | |
| NCT06118411 | Enrolling by invitation | Phase 3 | A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo | December 19, 2023 | February 5, 2028 |
| NCT06454461 | Not yet recruiting | N/A | Efficacy of Upadacitinib After NECS in Vitiligo | June 1, 2024 | June 1, 2029 |
| NCT05467839 | Not yet recruiting | N/A | Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourouracil in Treatment of Vitillgo Patients | July 31, 2022 | January 30, 2023 |
| NCT05544448 | Not yet recruiting | N/A | In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases | October 15, 2022 | April 15, 2023 |
| NCT05549869 | Not yet recruiting | N/A | Assessment of Serum Leptin in Vitiligo Patients | November 2022 | September 2023 |
| NCT05554523 | Not yet recruiting | How Does Skin Tone Affect Quantitative Photoacoustic Imaging | October 1, 2022 | October 15, 2023 | |
| NCT05569096 | Not yet recruiting | Tregs CD25 CXCL9 in Vitiligo | January 2024 | January 2026 | |
| NCT05706636 | Not yet recruiting | N/A | T Central Memory Cells in Early Localized Non-Segmental Vitiligo | February 2023 | September 2023 |
| NCT05812079 | Not yet recruiting | Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo | February 1, 2024 | October 1, 2024 | |
| NCT05869942 | Not yet recruiting | N/A | Histochemical Study of Vitiligo in Sohag University Hospital Patients | June 15, 2023 | August 15, 2024 |
| NCT06261073 | Not yet recruiting | N/A | Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients | March 15, 2024 | March 1, 2025 |
| NCT06261086 | Not yet recruiting | N/A | Evaluation of Pyroptosis-related Indicators in the Pathogenesis of Vitiligo:Across-sectional Comparative Study | February 24, 2024 | August 24, 2024 |
| NCT06324695 | Not yet recruiting | N/A | Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases | March 2024 | March 2025 |
| NCT04237103 | Recruiting | Phase 2 | Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo | May 23, 2023 | October 10, 2025 |
| NCT05536856 | Recruiting | Phase 4 | Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo | October 15, 2022 | April 30, 2024 |
| NCT06218082 | Recruiting | Vitiligo Registry for Adults and Children in the UK | May 31, 2024 | March 2029 | |
| NCT06410898 | Recruiting | N/A | Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo | April 25, 2024 | July 25, 2024 |
| NCT06446063 | Recruiting | Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients. | May 23, 2024 | June 1, 2025 | |
| NCT05991596 | Recruiting | N/A | Vitiligo and Psychodrama Therapy | November 2, 2023 | December 31, 2024 |
| NCT05607316 | Recruiting | Phase 2 | Evaluating the Efficacy and Safety of Metformin in Vitiligo | May 1, 2023 | November 1, 2027 |
| NCT05635266 | Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | October 26, 2021 | October 2025 | |
| NCT06319781 | Recruiting | A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo | December 15, 2023 | May 2025 | |
| NCT05836441 | Recruiting | N/A | Improved Phototherapy in Patients With Vitiligo | January 1, 2022 | December 30, 2023 |
| NCT06394349 | Recruiting | N/A | Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo | February 22, 2023 | October 14, 2024 |
| NCT05872477 | Recruiting | Phase 2 | Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas | September 5, 2023 | January 1, 2025 |
| NCT05917561 | Recruiting | Phase 2 | Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo | December 15, 2023 | May 1, 2026 |
| NCT05927272 | Recruiting | N/A | Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions | April 10, 2024 | October 9, 2025 |
| NCT06109649 | Recruiting | Phase 3 | A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo | October 11, 2023 | June 2025 |
| NCT04246372 | Recruiting | Phase 2 | Tofacitinib for Immune Skin Conditions in Down Syndrome | October 21, 2020 | December 2024 |
| NCT05210582 | Recruiting | Phase 2 | A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face | October 11, 2022 | August 2023 |
| NCT05233735 | Recruiting | N/A | Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo | January 1, 2021 | December 31, 2024 |
| NCT03577327 | Recruiting | The Gut and Skin Microbiome in Vitiligo Disease Progression | May 30, 2019 | December 2024 | |
| NCT04843059 | Recruiting | N/A | ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation | June 1, 2021 | May 30, 2025 |
| NCT03661866 | Recruiting | A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC | December 21, 2018 | December 2050 | |
| NCT06068218 | Recruiting | N/A | Translational Assessment of Vitiligo According to Body Locations | July 2, 2024 | October 2, 2025 |
| NCT06163326 | Recruiting | Phase 3 | A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo | January 19, 2024 | August 8, 2026 |
| NCT04774809 | Terminated | Phase 2/Phase 3 | Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo | January 29, 2020 | March 21, 2022 |
| NCT02506101 | Terminated | N/A | Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo | July 2015 | October 4, 2016 |
| NCT01923142 | Terminated | Phase 2 | Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo | January 2014 | June 2014 |
| NCT00771355 | Terminated | In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy | August 2008 | July 2010 | |
| NCT04811131 | Terminated | Phase 2 | Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo | March 4, 2021 | August 9, 2021 |
| NCT01262547 | Terminated | Phase 2 | A New Micrografting Technique for Vitiligo | September 2011 | May 2013 |
| NCT01259986 | Terminated | N/A | Treatment of Vitiligo With Low-energy Visible Light Laser | October 2010 | September 2012 |
| NCT05256147 | Terminated | N/A | Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-Photoadapters | August 2015 | May 24, 2016 |
| NCT04271501 | Terminated | N/A | Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions | September 25, 2020 | August 24, 2021 |
| NCT00177034 | Terminated | N/A | Examination Of Vitiligo Skin Samples Before and After UVB Treatment | November 2004 | December 2005 |
| NCT03022019 | Terminated | N/A | ReNovaCell in Non-segmental Vitiligo | December 2016 | May 14, 2019 |
| NCT02191748 | Terminated | Phase 2/Phase 3 | Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo | September 2014 | January 2018 |
| NCT04374435 | Terminated | N/A | Evaluating the Efficacy of the Melanocyte Keratinocyte Transplantation Procedure in the Treatment of Vitiligo | September 29, 2017 | May 1, 2022 |
| NCT01841008 | Terminated | Phase 2/Phase 3 | Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control | December 2011 | June 2014 |
| NCT00525395 | Unknown status | Phase 3 | Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol | April 2007 | June 2011 |
| NCT03872804 | Unknown status | N/A | Punch Minigraft Versus Transverse Needling or Combination of Both in Treatment of Non-Segmental Vitiligo | February 1, 2019 | March 1, 2021 |
| NCT03358082 | Unknown status | Phase 1/Phase 2 | Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo | October 1, 2017 | February 1, 2019 |
| NCT03340155 | Unknown status | N/A | Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases | October 30, 2017 | October 2022 |
| NCT03199664 | Unknown status | Phase 4 | Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo | September 1, 2017 | December 1, 2018 |
| NCT03976622 | Unknown status | Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata | June 3, 2019 | June 3, 2023 | |
| NCT04030988 | Unknown status | Phase 1 | Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVB | November 1, 2018 | November 2019 |
| NCT04039451 | Unknown status | Prevalence of Psoriasis and Vitiligo in Assiut Governorate, Egypt | September 1, 2019 | May 31, 2020 | |
| NCT03158675 | Unknown status | N/A | Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo | December 2018 | July 2019 |
| NCT04171427 | Unknown status | N/A | Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo | November 21, 2019 | May 2020 |
| NCT03155698 | Unknown status | N/A | Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma | August 2021 | December 2021 |
| NCT04308421 | Unknown status | N/A | Efficacy of Red Light in the Treatment of Pigmentary Disorders | March 1, 2020 | September 2020 |
| NCT04320160 | Unknown status | N/A | Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo | August 1, 2020 | October 24, 2022 |
| NCT03013049 | Unknown status | N/A | A Novel Surgical Method in the Treatment of Unstable Vitiligo | January 2016 | June 2017 |
| NCT02962180 | Unknown status | N/A | Transplantation of Basal Cell Layer Suspension Using Derma-rolling System in Vitiligo | March 2016 | December 2017 |
| NCT02925767 | Unknown status | N/A | Efficacy of 311-nm Ti:Sapphire Laser Versus 308-nm Excimer Laser Treatment in Vitiligo | August 2016 | August 30, 2018 |
| NCT04577027 | Unknown status | Phase 4 | Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo | January 1, 2021 | April 1, 2022 |
| NCT04734704 | Unknown status | N/A | Defining the Role of the Skin Microbiome in Immune-related Adverse Events | May 1, 2021 | May 1, 2023 |
| NCT02625012 | Unknown status | Repigmentation Patterns Induced by NB-UVB and Their Relationship With Melanocytic Migration in Vitiligo | January 2014 | April 2016 | |
| NCT04765826 | Unknown status | N/A | Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo | January 25, 2021 | August 2022 |
| NCT04789993 | Unknown status | Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up | March 15, 2021 | April 30, 2021 | |
| NCT02281058 | Unknown status | Phase 1 | Open-label Pilot Study of Abatacept for the Treatment of Vitiligo | January 2015 | May 2018 |
| NCT02038257 | Unknown status | N/A | Comparative Study Using Dermabrasion vs CO2 Laser & Collagen Dressing vs Vaseline Gauze in MKTP | January 2014 | July 2019 |
| NCT05008887 | Unknown status | Phase 4 | Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo | September 2022 | April 2023 |
| NCT01792245 | Unknown status | Phase 2 | Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand | February 2013 | |
| NCT01787708 | Unknown status | Phase 2 | Efficacy of Red Light in Vitiligo | February 2013 | |
| NCT01787695 | Unknown status | Phase 2 | UVA 1 Phototherapy for Vitiligo | February 2013 | |
| NCT05121532 | Unknown status | N/A | Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo | January 2022 | December 2022 |
| NCT05223738 | Unknown status | Resident Memory T Cells in Vitiligo | December 31, 2020 | February 1, 2022 | |
| NCT01766609 | Unknown status | Phase 2 | Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo | January 2013 | January 2016 |
| NCT05287776 | Unknown status | N/A | E-cadherin and Integrin Alpha v Beta 1 in Vitiligo | June 1, 2019 | December 1, 2022 |
| NCT05290077 | Unknown status | N/A | Role of NGAL in Vitiligo | December 15, 2022 | December 15, 2022 |
| NCT05293119 | Unknown status | Early Phase 1 | Role of Tofacitinib in Vitiligo Patients | May 30, 2022 | November 30, 2023 |
| NCT01459055 | Unknown status | Long-term Follow-up in Patients Affected With Acrofacial Vitiligo | May 2016 | August 2020 | |
| NCT05335746 | Unknown status | Ocular Changes in Vitiligo Patients on Therapy | March 10, 2022 | September 30, 2022 | |
| NCT01333410 | Unknown status | Phase 4 | Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo | June 2009 | December 2013 |
| NCT01006421 | Unknown status | Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo | January 2009 | January 2011 | |
| NCT00172939 | Unknown status | Phase 1 | Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model | June 2005 | January 2008 |
| NCT03497208 | Unknown status | N/A | Comparative Study of Surgical Treatment of Vitiligo | March 13, 2018 | December 13, 2019 |
| NCT03832751 | Unknown status | N/A | Human Beta-defensin 1 in Vitiligo | March 2019 | December 2019 |
| NCT03384459 | Unknown status | N/A | Maintenance Therapy of 308-nm Excimer Laser Therapy in Patients With Vitiligo | November 18, 2017 | May 18, 2019 |
| NCT03384342 | Unknown status | N/A | Maintenance Therapy of Narrow-band UV-B Therapy in Patients With Vitiligo | November 18, 2017 | May 18, 2019 |
| NCT03365141 | Unknown status | N/A | Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo | November 14, 2017 | September 15, 2018 |
| NCT00509314 | Unknown status | The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis | May 2006 | December 2016 | |
| NCT00484224 | Unknown status | Audiological Disturbances in Vitiligo | |||
| NCT00380471 | Unknown status | Phase 2 | Treatment and Complication of Bath PUVA in Vitiligo | January 2006 | August 2006 |
| NCT03611348 | Unknown status | Phase 2/Phase 3 | Microneedling and Latanoprost in Acrofacial Vitiligo | September 1, 2018 | December 1, 2019 |
| NCT03668834 | Unknown status | N/A | Comparing Recipient Site Preparation Using Dermabrasion, Dermaroller and Liquid Nitrogen Induced Blister in Non Cultured Epidermal Cell Suspension in Stable Vitiligo | January 1, 2018 | June 30, 2019 |
| NCT03717025 | Unknown status | N/A | Comparison of Surgical Methods on Resistant Sites in Stable Vitiligo Patients | July 1, 2017 | November 2018 |
| NCT03755830 | Unknown status | N/A | Prostaglandin F2-alpha (PGF2α) in Vitiligo | December 2018 | July 2019 |
| NCT01202513 | Withdrawn | Phase 4 | Topical Bimatoprost Solution 0.03%in Stable Vitiligo | August 2010 | November 2010 |
| NCT04858152 | Withdrawn | N/A | Hair Transplantation for Treatment of Vitiligo | August 1, 2021 | August 15, 2023 |
| NCT01419964 | Withdrawn | Phase 3 | Efficacy and Safety of ACH24 in the Treatment of Vitiligo | January 2012 | |
| NCT02290717 | Withdrawn | N/A | Fractional Laser in Combination With UVB Therapy in Vitiligo Patients | May 2015 | November 2015 |
| NCT01822379 | Withdrawn | Phase 2/Phase 3 | Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo | May 2010 | July 2012 |
- Disase is a (Disease Ontology)
- DOID:417
- Cross Reference ID (Disease Ontology)
- EFO:0004208
- Cross Reference ID (Disease Ontology)
- GARD:10751
- Cross Reference ID (Disease Ontology)
- ICD10CM:L80
- Cross Reference ID (Disease Ontology)
- ICD9CM:709.01
- Cross Reference ID (Disease Ontology)
- MESH:D014820
- Cross Reference ID (Disease Ontology)
- MIM:193200
- Cross Reference ID (Disease Ontology)
- NCI:C26915
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:156437000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0042900
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001045
- ICD10 preferred id (Insert disease from ICD10)
- D0009935
- ICD10 class code (Insert disease from ICD10)
- L80
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014820